AR029331A1 - Uso de derivados anticonvulsivos para la manufactura de un medicamento en el tratamiento de la bulimia nerviosa - Google Patents

Uso de derivados anticonvulsivos para la manufactura de un medicamento en el tratamiento de la bulimia nerviosa

Info

Publication number
AR029331A1
AR029331A1 ARP000100410A ARP000100410A AR029331A1 AR 029331 A1 AR029331 A1 AR 029331A1 AR P000100410 A ARP000100410 A AR P000100410A AR P000100410 A ARP000100410 A AR P000100410A AR 029331 A1 AR029331 A1 AR 029331A1
Authority
AR
Argentina
Prior art keywords
manufacture
convulsive
derivatives
treatment
alkyl
Prior art date
Application number
ARP000100410A
Other languages
English (en)
Spanish (es)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR029331A1 publication Critical patent/AR029331A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ARP000100410A 1999-02-01 2000-01-31 Uso de derivados anticonvulsivos para la manufactura de un medicamento en el tratamiento de la bulimia nerviosa AR029331A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11805799P 1999-02-01 1999-02-01

Publications (1)

Publication Number Publication Date
AR029331A1 true AR029331A1 (es) 2003-06-25

Family

ID=22376270

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100410A AR029331A1 (es) 1999-02-01 2000-01-31 Uso de derivados anticonvulsivos para la manufactura de un medicamento en el tratamiento de la bulimia nerviosa

Country Status (23)

Country Link
EP (1) EP1148874B1 (zh)
JP (1) JP2002535363A (zh)
KR (1) KR100664618B1 (zh)
CN (1) CN1196482C (zh)
AR (1) AR029331A1 (zh)
AT (1) ATE255892T1 (zh)
AU (1) AU764703B2 (zh)
BR (1) BR0007897A (zh)
CA (1) CA2360677C (zh)
CZ (1) CZ295594B6 (zh)
DE (1) DE60007078T2 (zh)
DK (1) DK1148874T3 (zh)
ES (1) ES2211507T3 (zh)
HU (1) HUP0105420A3 (zh)
IL (1) IL144407A0 (zh)
MX (1) MXPA01007758A (zh)
NO (1) NO20013725D0 (zh)
NZ (1) NZ513114A (zh)
PT (1) PT1148874E (zh)
TR (1) TR200102205T2 (zh)
TW (1) TW565446B (zh)
WO (1) WO2000044374A1 (zh)
ZA (1) ZA200107212B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
AU779248B2 (en) 1999-02-24 2005-01-13 University Of Cincinnati, The Use of sulfamate derivatives for treating impulse control disorders
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US6462084B1 (en) * 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.

Also Published As

Publication number Publication date
CA2360677A1 (en) 2000-08-03
CA2360677C (en) 2005-07-05
KR20010101665A (ko) 2001-11-14
ES2211507T3 (es) 2004-07-16
DE60007078T2 (de) 2004-12-16
KR100664618B1 (ko) 2007-01-04
IL144407A0 (en) 2002-05-23
HUP0105420A2 (hu) 2002-05-29
PT1148874E (pt) 2004-04-30
JP2002535363A (ja) 2002-10-22
CN1338931A (zh) 2002-03-06
NO20013725L (no) 2001-07-30
MXPA01007758A (es) 2003-06-24
BR0007897A (pt) 2001-10-30
NZ513114A (en) 2003-10-31
NO20013725D0 (no) 2001-07-30
WO2000044374A1 (en) 2000-08-03
AU2746200A (en) 2000-08-18
TW565446B (en) 2003-12-11
AU764703B2 (en) 2003-08-28
ZA200107212B (en) 2002-12-02
DE60007078D1 (de) 2004-01-22
DK1148874T3 (da) 2004-03-29
CZ295594B6 (cs) 2005-08-17
EP1148874B1 (en) 2003-12-10
CN1196482C (zh) 2005-04-13
EP1148874A1 (en) 2001-10-31
ATE255892T1 (de) 2003-12-15
HUP0105420A3 (en) 2003-03-28
TR200102205T2 (tr) 2002-01-21

Similar Documents

Publication Publication Date Title
AR032465A1 (es) Derivados anticonvulsivos utiles para la preparacion de un medicamento para prevenir el desarrollo de la diabetes mellitus de tipo ii y del sindrome x
DE3783988D1 (de) Zyklische enolderivate, herstellung und anwendung.
WO2000042996A3 (en) Use of anticonvulsant derivatives for treating cluster headaches
CA2369099A1 (en) Anticonvulsant derivatives useful in reducing blood glucose levels
CA2369095A1 (en) Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
AR043355A1 (es) Compuestos derivados de amida, preparacion de medicamentos que los contienen para el tratamiento y prevencion de trastornos asociados con glucocorticoides
HUP0203225A2 (hu) Benzodiazepinszármazékok, előállításuk és alkalmazásuk
LV12792B (en) Formyl- or cyano- substituted indole derivatives having dopaminergic activity
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
EP0194161A3 (en) Cyclopentaûd¨pyrimidine derivatives, their preparation and use
AR029334A1 (es) Uso de derivados anti-convulsivos para la manufactura de un medicamento para el tratamiento del autismo
AR029331A1 (es) Uso de derivados anticonvulsivos para la manufactura de un medicamento en el tratamiento de la bulimia nerviosa
WO2000042995A3 (en) Use of anticonvulsant derivatives for treating transformed migraine
NZ334981A (en) Anti-convulsant derivatives such as topiramate for treating neuropathic pain
AR034088A1 (es) Composicion que comprende derivados anticonvulsivantes utiles en el tratamiento de esquizofrenia y el uso de dicho derivado para la manufactura de un medicamento
NZ333587A (en) Topiramate derivatives useful in treating psoriasis
WO2000023059A3 (en) Use of anticonvulsant derivatives for treating alcohol dependency
ATE32720T1 (de) 1,3,4,6,7,11b-hexahydro-7-aryl-2h-pyrazino(2,1alpha)isochinoline als zwischenprodukte und als pharmazeutische verbindungen verwendbar und methode zu ihrer herstellung.
FI860074A0 (fi) Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel.
ES2041679T3 (es) Compuestos analgesicos de octohidroindolizinas 5-substituidas y productos intermedios 7-ceto.
NZ513724A (en) Anticonvulsant derivatives useful in treating essential tremor
AR035005A1 (es) Composicion para el tratamiento del trastorno por estres post traumatico
NO180487C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksadiazolylfenoksyalkylisoksazoler
WO2000066108A3 (en) Anticonvulsant derivatives useful in treating cocaine dependency
NO180635C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv tetracyklisk imidazolinforbindelse

Legal Events

Date Code Title Description
FA Abandonment or withdrawal